MOPA — Medical Oncology Prior Authorization
0.1.1-snapshot-080926 - snapshot-080926
MOPA — Medical Oncology Prior Authorization
0.1.1-snapshot-080926 - snapshot-080926
MOPA — Medical Oncology Prior Authorization - Local Development build (v0.1.1-snapshot-080926) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Profile: Anti-Cancer Regimen RequestGroup
Request Category: Adjuvant - intent
Request Category: First-line
instantiatesCanonical: ddAC→T: Dose-Dense Doxorubicin/Cyclophosphamide then Paclitaxel — Breast Cancer
status: Draft
intent: Order
subject: Jane Smith (official) Female, DoB: 1968-04-15 ( http://hospital.example.org/patients#MRN-78432)
action
id
ac-phase-ordertitle: AC Phase (Cycles 1–4, q14d)
timing: Count 4 times, Once per 14 days
action
id
doxorubicin-actiontitle: Doxorubicin 60 mg/m² IV day 1
timing: Once per 14 days
resource: MedicationRequest: status = draft; intent = order; medication[x] = doxorubicin
action
id
cyclophosphamide-actiontitle: Cyclophosphamide 600 mg/m² IV day 1
timing: Once per 14 days
resource: MedicationRequest: status = draft; intent = order; medication[x] = cyclophosphamide
action
id
pegfilgrastim-actiontitle: Pegfilgrastim 6 mg subcutaneous day 2
timing: Once per 14 days
resource: MedicationRequest: status = draft; intent = order; medication[x] = pegfilgrastim
action
id
t-phase-ordertitle: T Phase — Paclitaxel (Cycles 5–8, q14d)
RelatedActions
ActionId Relationship ac-phase-order After End timing: Count 4 times, Once per 14 days
action
id
paclitaxel-t-actiontitle: Paclitaxel 175 mg/m² IV day 1
timing: Once per 14 days
resource: MedicationRequest: status = draft; intent = order; medication[x] = paclitaxel
IG © 2026+ HL7 International / Clinical Interoperability Council.
Package hl7.fhir.us.codex-mopa#0.1.1-snapshot-080926 based on FHIR 4.0.1.
Generated
2026-09-08
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change